Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Ceretas Ltd

CTS.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Pharmaceuticals ·

Australia N/A Analyst: N/A

Last Close

$0.68

▲ +7.39%

Market Cap N/A · Vol 79.88K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

N/A

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

57.97

Momentum

Beta

N/A

vs Market

52W High

$0.80

15.27% below

52W Low

$0.31

126.11% above

Volume

79.88K

Avg 152.86K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

58.46%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Ceretas Ltd (CTS.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CTS.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-12.50%

+60.17%

N/A

YTD

N/A

Financials & Valuation

TTM · Annual

Total Revenue	N/A
Net Income	N/A
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	N/A · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	48.42M

Technical Indicators

50-Day SMA	$N/A
200-Day SMA	$N/A
RSI (14)	57.97
Beta	N/A
52-Week High	$0.80
52-Week Low	$0.31

Volume Today	79.88K
Avg Daily Volume (30D)	152.86K
Relative Volume	0.52x
Volatility (10D)	100.21
Volatility (30D)	77.72
Free Float	58.46%

Analyst Consensus

N/A

Current Price $0.68

Mean Target N/A

52W Low$0.31 52W High$0.80

Current

Target

$0.31 $0.80

Current Analyst target

· 0 analysts

Identifiers

ExchangeASX

FIGIN/A

ISINAU0000475766

CountryAustralia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Company -0.65% JNJ Johnson & Johnson -0.29% ABBV AbbVie Inc. +0.83% NVS Novartis AG -0.23% NOVN.S Novartis AG -0.09%

Company Profile

Ceretas Limited is an Australia-based medical technology company. The Company is engaged in developing a portable, non-invasive therapeutic ultrasound platform for the treatment of Alzheimer's disease and other neurodegenerative conditions (Ceretas Device). The Company's initial clinical focus is neuromodulation, which uses low-intensity focused ultrasound to stimulate neural circuits involved in memory, cognition and mood. The Ceretas Device is a therapeutic ultrasound platform that delivers low-intensity focused ultrasound non-invasively through the skull to targeted regions of the brain. The system integrates three core components: a focused ultrasound transducer and signal chain that generates and delivers the acoustic energy; a fluid coupling system that ensures efficient transmission of ultrasound from the transducer to the scalp, and an image-guided neuronavigational system which directs the transducer to precise brain targets based on each patient’s individual MRI scan.